Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2009 4
2010 27
2011 6
2012 5
2013 4
2014 6
2015 6
2016 15
2017 10
2018 10
2019 5
2020 8
2021 15
2022 21
2023 11
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

139 results

Results by year

Filters applied: . Clear all
Page 1
Pembrolizumab given concomitantly with chemoradiation and as maintenance therapy for locally advanced head and neck squamous cell carcinoma: KEYNOTE-412.
Machiels JP, Tao Y, Burtness B, Tahara M, Licitra L, Rischin D, Waldron J, Simon C, Gregoire V, Harrington K, Alves GV, Figueiredo Lima IP, Pointreau Y, M Hughes BG, Aksoy S, Hetnal M, Ge JY, Brown H, Cheng J, Bidadi B, Siu LL. Machiels JP, et al. Among authors: pointreau y. Future Oncol. 2020 Jun;16(18):1235-1243. doi: 10.2217/fon-2020-0184. Epub 2020 Jun 3. Future Oncol. 2020. PMID: 32490686 Free article.
Extended follow-up of a phase 2 trial of xevinapant plus chemoradiotherapy in high-risk locally advanced squamous cell carcinoma of the head and neck: a randomised clinical trial.
Tao Y, Sun XS, Pointreau Y, Le Tourneau C, Sire C, Kaminsky MC, Coutte A, Alfonsi M, Calderon B, Boisselier P, Martin L, Miroir J, Ramee JF, Delord JP, Clatot F, Rolland F, Villa J, Magne N, Elicin O, Gherga E, Nguyen F, Lafond C, Bera G, Calugaru V, Geoffrois L, Chauffert B, Damstrup L, Crompton P, Ennaji A, Gollmer K, Nauwelaerts H, Bourhis J. Tao Y, et al. Among authors: pointreau y. Eur J Cancer. 2023 Apr;183:24-37. doi: 10.1016/j.ejca.2022.12.015. Epub 2023 Jan 9. Eur J Cancer. 2023. PMID: 36796234 Free article. Clinical Trial.
Low-level laser therapy in treatment of chemoradiotherapy-induced mucositis in head and neck cancer: results of a randomised, triple blind, multicentre phase III trial.
Legouté F, Bensadoun RJ, Seegers V, Pointreau Y, Caron D, Lang P, Prévost A, Martin L, Schick U, Morvant B, Capitain O, Calais G, Jadaud E. Legouté F, et al. Among authors: pointreau y. Radiat Oncol. 2019 May 22;14(1):83. doi: 10.1186/s13014-019-1292-2. Radiat Oncol. 2019. PMID: 31118057 Free PMC article. Clinical Trial.
Radiotherapy for laryngeal cancers.
Biau J, Pointreau Y, Blanchard P, Khampan C, Giraud P, Lapeyre M, Maingon P. Biau J, et al. Among authors: pointreau y. Cancer Radiother. 2022 Feb-Apr;26(1-2):206-212. doi: 10.1016/j.canrad.2021.09.004. Epub 2021 Dec 22. Cancer Radiother. 2022. PMID: 34953705
Radiotherapy of sinonasal cancers.
Larnaudie A, Delaby N, Marcy PY, Leleu T, Costes-Martineau V, Vergez S, de Gabory L, Quintyn JC, Doré M, Pointreau Y, Thariat J. Larnaudie A, et al. Among authors: pointreau y. Cancer Radiother. 2022 Feb-Apr;26(1-2):156-167. doi: 10.1016/j.canrad.2021.10.007. Epub 2021 Dec 22. Cancer Radiother. 2022. PMID: 34953697
Debio 1143 and high-dose cisplatin chemoradiotherapy in high-risk locoregionally advanced squamous cell carcinoma of the head and neck: a double-blind, multicentre, randomised, phase 2 study.
Sun XS, Tao Y, Le Tourneau C, Pointreau Y, Sire C, Kaminsky MC, Coutte A, Alfonsi M, Boisselier P, Martin L, Miroir J, Ramee JF, Delord JP, Clatot F, Rolland F, Villa J, Magne N, Elicin O, Gherga E, Nguyen F, Lafond C, Bera G, Calugaru V, Geoffrois L, Chauffert B, Zubel A, Zanna C, Brienza S, Crompton P, Rouits E, Gollmer K, Szyldergemajn S, Bourhis J. Sun XS, et al. Among authors: pointreau y. Lancet Oncol. 2020 Sep;21(9):1173-1187. doi: 10.1016/S1470-2045(20)30327-2. Epub 2020 Aug 3. Lancet Oncol. 2020. PMID: 32758455 Clinical Trial.
AFSOS-SFRO-SFH-SFNEP-SFCE-GFRP guidelines on radio-induced nausea and vomiting.
Faivre JC, Tomaszewski F, Demoor-Goldschmitt C, Beddok A, Malgras A, Schmitt A, Fabre J, Perrot A, Jovenin N, Salleron J, Clavère P, Pointreau Y, Scotté F, Bensadoun RJ, Block V, Thariat J. Faivre JC, et al. Among authors: pointreau y. Crit Rev Oncol Hematol. 2022 Dec;180:103825. doi: 10.1016/j.critrevonc.2022.103825. Epub 2022 Oct 9. Crit Rev Oncol Hematol. 2022. PMID: 36223807 Review.
Radiotherapy for hypopharynx cancers.
Pointreau Y, Biau J, Delaby N, Thariat J, Lapeyre M. Pointreau Y, et al. Cancer Radiother. 2022 Feb-Apr;26(1-2):199-205. doi: 10.1016/j.canrad.2021.10.006. Epub 2021 Dec 22. Cancer Radiother. 2022. PMID: 34953703
Radiotherapy for oral cavity cancers.
Lapeyre M, Racadot S, Renard S, Biau J, Moreira JF, Biston MC, Pointreau Y, Thariat J, Graff-Cailleaud P. Lapeyre M, et al. Among authors: pointreau y. Cancer Radiother. 2022 Feb-Apr;26(1-2):189-198. doi: 10.1016/j.canrad.2021.11.012. Epub 2021 Dec 23. Cancer Radiother. 2022. PMID: 34953711
139 results